Endoscopic endonasal surgery
Endoscopic endonasal surgery | |
---|---|
Specialty | otolaryngology |
Endoscopic endonasal surgery is a
Introduction
History of endoscopic endonasal surgery
Antonin Jean Desomeaux, a urologist from Paris, was the first person to use the term, endoscope.[1] However, the precursor to the modern endoscope was invented in the 1800s when a physician in Frankfurt, Germany by the name of Philipp Bozzini, developed a tool to see the inner workings of the body.[2] Bozzini called his invention a Light Conductor, or Lichtleiter in German, and later wrote about his experiments on live patients with this device that consisted of an eyepiece and a container for a candle.[1] Following Bozzini's success, The University of Vienna starting using the device to test its practicality in other forms of medicine. After Bozzini's device received negative results from live human trials, it had to be discontinued. However, Maximilian Nitze and Joseph Leiter used the invention of the light bulb by Thomas Edison to make a more refined device similar to modern day endoscopes. This iteration was used for urological procedures, and eventually otolaryngologists began to use Nitze and Leiter's device for eustachian tube manipulation and removal of foreign bodies.[2] The endoscope made its way to the US when Walter Messerklinger began teaching David Kennedy at Johns Hopkins Hospital.[citation needed]
The transsphenoidal and intracranial approaches to pituitary tumors began in the 1800s but with little success. Gerard Guiot popularized the transphenoidal approach which later became part of the neurosurgical curriculum, however he himself discontinued the use of this technique because of inadequate sight.[1] In the late 1970s, the endoscopic endonasal approach was used by neurosurgeons to augment microsurgery which allowed them to view objects out of their line of sight. Another surgeon, Axel Perneczky, is considered to be a pioneer of the use of an endoscope in neurosurgery. Perneczky said that endoscopy, "improved appreciation of micro-anatomy not apparent with the microscope."[1]
The surgery was pioneered in Algeria by Bouyoucef Kheireddine and Faiza Lalam.[3][4]
Endoscopic instrumentation
The endoscope consists of a glass fiber bundle for cold light illumination, a mechanical housing, and an optics component with four different views: 0 degree for straight forward, 30 degrees for forward plane, 90 degrees for lateral view, and 120 degrees for retrospective view.[5] For endoscopic endonasal surgery, rigid rod-lens endoscopes are used for better quality of vision, since these endoscopes are smaller than the normal endoscope used colonoscopies.[2] The endoscope has an eyepiece for the surgeon, but it is rarely used because it requires the surgeon to be in a fixed position. Instead, a video camera broadcasts the image to a monitor that shows the surgical field.[citation needed]
Areas of interest for surgical planning
Several specialties need to be involved to determine the complete surgical plan. These include: an Endocrinologist, a Neuroradiologist, an Ophthalmologist, a Neurosurgeon, and an Otolaryngologist.
Endocrinology
An endocrinologist is only involved in preparation for an endoscopic endonasal surgery, if the tumor is located on the pituitary gland. The tumor is first treated
- PRL-secreting or prolactinomas: These are the most common pituitary tumors. They are associated with infertility, gonad, and sexual dysfunction because they increase the secretion of prolactin or PRL. One drug that endocrinologist use is bromocriptine (BRC), which normalizes PRL levels and has been shown to lead to tumor shrinkage. Other drugs to treat prolactinomas include quinagolide (CV) or cabergoline (CAB) acting as dopamine (D2) antagonists. Endoscopic endonasal surgery is normally performed as a last resort when the tumor is resistant to the drugs, shows no tumor shrinkage, or the PRL levels cannot be normalized.[5]
- GH-secreting: A very rare condition that is a result of the increase in the secretion of pharmacological therapy has had little effect on these tumors, a trans-sphenoidal surgery to remove part of the pituitary gland is the first treatment option.[5]
- TSH-secreting: Another rare condition only resulting in 1% of pituitary surgeries is a result of the increase in the secretion of the thyroid-stimulating hormone. This tumor leads to hyperthyroidism, resulting in headaches and visual disturbances. Although surgery is the first step of treatment, it does not usually cure the patient. After surgery, patients are treated by somatostatin analogues, a type of hormone replacement therapy, because TSH related tumors increase the expression of somatostatin receptors.[5]
- ACTH-secreting: This tumor is a result of the increase in the secretion of adrenocorticotropic hormone (ACTH) and leads to Cushing's syndrome. Pharmacology has little effect and therefore surgery is the best option. Removal of the tumor results in an 80%-90% cure rate.[5]
Neuroradiology
A neuroradiologist takes images of the defect so that the surgeon is prepared on what to expect before surgery. This includes identifying the lesion or tumor, controlling the effects of the medical therapy, defining the spatial situation of the lesions, and verifying the removal of the lesions.[5] The lesions associated with endoscopic endonasal surgery include:
- Pituitary microadenomas
- Pituitary macroadenomas
- Rathke's cleft cysts
- Pituitary inflammatory disease
- Pituitary metastasis
- Empty Sella
- Craniopharyngiomas
- Meningiomas
- Chiasmatic and Hypothalamic gliomas
- Germinomas
- Tuber Cinereum Hamartomas
- Arachnoid cysts
- Neurinomas of the trigeminal nerve
Ophthalmology
Some
- Visual field defects
- Reduced visual activity
- Visually evoked potential(VEP) abnormalities
- Color blindness
- Eye motility impairment
Surgical approaches to the anterior skull base
Transnasal approach
The transnasal approach is used when the surgeon needs to access the roof of the nasal cavity, the
Transsphenoidal approach
This approach is the most common and useful technique of endoscopic endonasal surgery and was first described in 1910 concurrently by Harvey Cushing and Oskar Hirsch.[6][7] This procedure allows the surgeon to access the sellar space, or sella turcica. The sella is a cradle where the pituitary gland sits. Under normal circumstances, a surgeon would use this approach on a patient with a pituitary adenoma. The surgeon starts with the transnasal approach prior to using the transsphenoidal approach. This allows access to the sphenoid ostium and sphenoid sinus. The sphenoid ostium is located on the anterosuperior surface of the sphenoid sinus. The anterior wall of the sphenoid sinus and the sphenoid rostrum is then removed to allow the surgeon a panoramic view of the surgical area.[2] This procedure also requires the removal of the posterior septum to allow the use of both nostrils for tools during surgery. There are several triangles of blood vessels traversing this region, which are just very delicate areas of blood vessels that can be deadly if injured.[2][8] A surgeon uses stereotactic imaging and a micro Doppler to visualize the surgical field.
The invention of the angled endoscope is used to go beyond the
Transpterygoidal approach
The transpterygoidal approach enters through the posterior edge of the
Transethmoidal approach
This approach makes a surgical corridor from the
Different approaches to specific regions
Approach to sellar region
For removal of a small tumor, it is accessed through one nostril. However, for larger tumors, access through both nostrils is required and the posterior nasal
Approach to suprasellar region
This technique is the same as to the sellar region. However the tuberculum sellae is drilled into instead of the sella. Then an opening is made that extends halfway down the sella to expose the dura, and the intercavernous sinuses is exposed. When the optic chiasm, optic nerve, and pituitary gland are visible, the pituitary gland and optic chasm are pushed apart to see the pituitary stalk. An ethmoidectomy is performed,[2] the dura is then cut, and the tumor is removed. These types of tumors are separated into two types:
- Prechiasmal Lesions: This tumor is closest to the dura. The tumor is decompressed by the surgeon. After decompression, the tumor is removed taking care to not disrupt any optic nerve or major arteries.[2]
- Postchiasmal Lesions: This time the pituitary stalk is in the front because the tumor is pushing it towards the area the dura was opened. Removal then starts on both sides of the stalk to preserve the connection between the pituitary and the hypothalamus and above pituitary gland to protect the stalk. The tumor is carefully removed and the patient is closed up.[2]
Skull base reconstruction
When there is a tumor, injury, or some type of defect at the skull base whether the surgeon used an endoscopic or open surgical method, the problem still arises of providing separation of the cranial cavity and cavity between the sinuses and nose to prevent cerebrospinal fluid leakage through the opening referred to as a defect.[11]
For this procedure, there are two ways to start: with a free graft repair or with a vascularized flap repair. The free grafts use secondary material like cadaver flaps or titanium mesh to repair the skull base defects, which is very successful (95% without CSF leaks) with small CSF fistulas or small defects.[12] The local or regional vascularized flaps are pieces of tissue relatively close to the surgery site that have been mostly freed up but are still attached to the original tissue. These flaps are then stretched or maneuvered onto the desired location. When technology advanced and larger defects could be fixed endoscopically, more and more failures and leaks started to occur with the free graft technique. The larger defects are associated with a wider dural removal and an exposure to high flow CSF, which could be the reason for failure among the free graft.[12]
Pituitary gland surgery
This surgery is turned from a very serious surgery into a minimally invasive one through the nose with the use of the endoscope. For instance craniopharyngiomas (CRAs) are starting to be removed via this method. Dr. Paolo Cappabianca described the perfect CRA for this surgery to be a median lesion with a solid parasellar component (beside the sellar) or encasement of the main neuromuscular structures that are localized in the subchiasmatic (below the optic chiasm) and retrochiasmatic (behind the optic chiasm) regions. He also says that when these conditions are met, endoscopic endonasal surgery is a valid surgical option.[13] For a case study on large adenomas, the doctors showed that out of 50 patients, 19 had complete tumor removal, 9 had near complete removal, and 22 had partial removal. The partial removal came from the tumors extending into more dangerous areas. They concluded that endoscopic endonasal surgery was a valid option for surgery if the patients used pharmacological therapy after surgery.[14] Another study showed that with endoscopic endonasal surgery 90% of microadenomas could be removed, and that 2/3 of normal macroadenomas could be removed if they did not go into the cavernous sinus, which means fragile blood vessel triangles would have to be dealt with so only 1/3 of those patients recovered.[15] Endoscopic endonasal approach has been shown even among young patients to be superior to traditional microscopic transsphenoidal surgery.[16]
3-D approach vs 2-D approach
The newer 3-D technique is gaining ground as the ideal way to do surgery because it gives the surgeon a better understanding of the spatial configuration of what they are seeing on a computer screen. Dr. Nelson Oyesiku at Emory University helped develop the 3-D technique. In an article he helped write, he and the other authors compared the effects of the 2-D technique vs the 3-D technique on patient outcome. It showed that the 3-D endoscopy gave the surgeon more depth of field and stereoscopic vision and that the new technique did not show any significant changes in patient outcomes during or after surgery.[17]
Endoscopic techniques vs open techniques
In a case study from 2013, they compared the open vs endoscopic techniques for 162 other studies that contained 5,701 patients.
References
- ^ S2CID 43877814.
- ^ ISBN 978-1-59756-060-3.
- ^ Kreo (2014). "Santé: Tizi-Ouzou: Lancement de la chirurgie par voie endoscopique au CHU". DKNews (in French). Retrieved 2022-04-22.
- ^ Kreo (2014). "Endoscope air water channel". DKNews. Retrieved 2022-04-22.
- ^ ISBN 978-3-211-00972-7.
- PMID 16381201.
- ^ Lanzino G, Laws ER Jr, Feiz-Erfan I, White WL (2002). "Transsphenoidal Approach to Lesions of the Sella Turcica: Historical Overview". Barrow Quarterly (3) (18 ed.). Archived from the original on 4 April 2015. Retrieved 3 December 2013.
- S2CID 264924552.
- ^ PMID 25093148.
- S2CID 22891605.
- PMID 17603646.
- ^ S2CID 34402474.
- PMID 22120287.
- PMID 23994073.
- .
- PMID 33338824.
- S2CID 20651117.
- PMID 24014055.
- PMID 22501020.